3 Little-Known Stocks I'm Glad I Bought
Ophthotech Corp, Portola Pharmaceuticals Inc., and Insys Therapeutics Inc., have been top performers this past year.
2 Tiny Biotechs That Could Have Blockbuster Opportunity
Got risk tolerance? Check out these two small cap biotechs with huge potential.
In Case You Missed It, This New Cancer Care Cost Study Is Extremely Disappointing
We'd like to think that the billions of dollars being spent annually on cancer drug development are making a sizable impact on the lives of cancer patients. But, that may not be the case, according to this latest study.